In the adult, the heart rate is driven by spontaneous and repetitive depolarizations of pacemaker cells to generate a firing of action potentials propagating along the conduction system and spreading into the ventricles. In the early embryo before E9.5, the pacemaker ionic channel responsible for the spontaneous depolarization of cells is not yet functional. Thus the mechanisms that initiate early heart rhythm during cardiogenesis are puzzling. In the absence of a functional pacemaker ionic channel, the oscillatory nature of inositol 1,4,5-trisphosphate (InsP 3 )-induced intracellular Ca 2؉ signaling could provide an alternative pacemaking mechanism. To test this hypothesis, we have engineered pacemaker cells from embryonic stem (ES) cells, a model that faithfully recapitulates early stages of heart development. We show that InsP 3 -dependent shuttle of free Ca 2؉ in and out of the endoplasmic reticulum is essential for a proper generation of pacemaker activity during early cardiogenesis and fetal life.
INTRODUCTION
The heart rate is initiated and driven by dominant pacemaker cells located in the sino-atrial node of adult myocardium. These cells feature at their membrane a functional pacemaker channel, namely the hyperpolarization-activated cyclic nucleotide (HCN)-gated cationic channel, generating the I f current and setting the spontaneous and rhythmic action potentials of the heart (Accili et al., 2002; Clapham, 1998) . The first cell contractions are observed in the murine embryo as early as E7.5 (Porter and Rivkees, 2001) , despite the small amplitude of the I f current recorded before E9.5 (Stieber et al., 2003) . Interestingly, mice deficient for HCN4, the predominant HCN message in the sino-atrial node, live without cardiac arrhythmias till embryonic day 9.5-11.5 despite the absence of mature cAMP-regulated pacemaker cells in their heart (Stieber et al., 2003) . This suggests that HCN-independent, not yet described mechanisms must be responsible for a pacemaker activity at the early stages of cardiac development. Such a mechanism is crucial because it would allow for contraction of the cardiac tube and of the fully developed embryonic heart to ensure viability of the embryo till midgestation.
The various roles of Ca 2ϩ as an intracellular second messenger have been characterized extensively. This cation regulates such important biological processes as contraction, cell migration, secretion, growth and differentiation (Clapham, 1995; Rizzuto et al., 2002; Berridge et al., 2003; Webb and Miller, 2003) . Importantly, the action of intracellular Ca 2ϩ begins at very early stages of development affecting pathways involved in fertilization and embryogenesis (Berridge et al., 2000 (Berridge et al., , 2003 Webb and Miller, 2003) . Ca 2ϩ is released from the endoplasmic reticulum (ER) by inositol 1,4,5-trisphosphate (InsP 3 ) generated after phospholipase C activation, decoding the signal conveyed by extracellular growth factors, hormones, or neurotransmitters. In turn, Ca 2ϩ depletion of the ER triggers a capacitative Ca 2ϩ influx (CCI) across the plasma membrane to refill the stores (Putney et al., 2001; Venkatachalam et al., 2002) . The oscillatory nature of the InsP 3 -induced intracellular Ca 2ϩ signal has been long recognized (Hirose et al., 1999; Berridge et al., 2003) . We hypothesize that InsP 3 -induced intracellular Ca 2ϩ oscillations, generating rhythmic repetitions of events over time intervals, may provide a pacing mechanism in embryonic heart.
It is difficult to investigate the molecular basis of cardiac pacemaker activity in the murine embryo. Although knockout or targeted mutations of specific genes might provide valuable information to address this question, the dependence of the murine embryo upon blood flow and thus myocardial function makes this approach and interpretation of the results intricate because any defect in heart function may compromise the survival of the embryo. To overcome this problem, here we used differentiating embryonic stem (ES) cell-derived cardiomyocytes, which recapitulate in vitro the early stages of cardiogenesis (Leahy et al., 1999; Loebel et al., 2003) . We engineered pacemaker cells with disrupted intracellular Ca 2ϩ signaling by overexpression of calreticulin, an ER Ca 2ϩ -buffering protein or by knocking down expression of type I InsP 3 receptor. These genetic approaches were combined with a pharmacological strategy together with cell biology technologies designed to specifically target InsP 3 signaling. We demonstrate that intracellular Ca 2ϩ oscillations supported by InsP 3 -sensitive stores constitute a pacemaking mechanism in early cardiac development. Furthermore, we uncovered that this intracellular Ca 2ϩ network is also essential in mediating pacemaker activity in fetal heart.
MATERIALS AND METHODS

ES Cell Propagation and Differentiation
ES cells (CGR8) were propagated in BHK21 medium supplemented with sodium pyruvate, nonessential amino acids, mercaptoethanol, 7.5% fetal calf serum (FCS; Hyclone, Perbio, France) and leukemia inhibitory factor (LIF)-conditioned medium. Differentiation was carried out using the hanging drop method. Briefly, embryoid bodies (EB) were formed in hanging drops of differentiation medium (BHK21 medium supplemented with Na pyruvate, nonessential amino acids, selenium, ␤-mercaptoethanol, and 20% FCS, without LIF) for 2 d (D0 -2). Then, the embryoid bodies were incubated for 3 d in suspension (D3-5) and plated on gelatin-coated dishes at day 6.
Plasmid Construction, ES Cell Clones, and ES Cell Differentiation
A cDNA encoding rabbit calreticulin was subcloned downstream the ␣-MHC promoter (GenBank U71441; Nakamura et al., 2001) . To generate an InsP 3 RI antisense cDNA, a region (420 base pairs, nucleotides 834-1254 from ATG) of the InsP 3 binding domain of the InsP 3 RI was amplified by PCR from a brain cDNA library using two primers including an enzyme restriction site, taaagcccggggggaagtggaggta (XmaI) and gctgaaaattggtacctctcccct (KpnI). The PCR fragment was then subcloned in a vector in the antisense orientation downstream the ␣-MHC promoter. The linearized plasmids were electroporated into CGR8 ES cells according to standard protocol. The ES cell clones were selected for 10 d with G418 (250 g/ml) and screened by PCR before differentiation using the hanging drop method (Meyer et al., 2000) . Two separate ES cell clones from each clone were used in the study. To monitor the expression of the antisense mRNA, total RNA extracted from embryoid bodies was reverse-transcribed using the sense primer (taaagcccggggggaagtggaggta). The resulting products were then amplified by real-time quantitative PCR using the primers listed above and run on agarose gel.
Cell Microdissection and Combined Approaches
Beating areas of EBs featuring EYFP-expressing cells were dissected with a laser-assisted device (PALM Laser, Bernried, Germany) or a microscalpel and cells were enzymatically isolated using 1 mg/ml collagenase in ADS buffer without Ca 2ϩ (containing 20 mM HEPES, 5 mM glucose, 117 mM NaCl, 5.7 mM KCl, 1.2 mM NaH 2 PO 4 , 4.4 mM NaHCO 3 , 1.7 mM MgCl 2 ). Cells were then plated in differentiation medium on gelatin-coated dishes. Real time PCR was carried out on dissected EYFP-expressing cells after reverse transcription from RNA extracted using a RNA extraction kit (PALM Laser).
Electrophysiology
Electrophysiological recordings were made at room temperature (25 Ϯ 2°C) using an Axopatch-200 patch clamp amplifier (Axon Instruments, Foster City, CA) and analyzed using the Clampfit 9 software (Axon Instruments). Monitoring of action potentials (AP) in ES cell-derived pacemaker cells was performed as early as 24 h after their isolation and no longer than 48 h after with no change in morphology, or electrical properties during the 2-d culture. AP were recorded with a 30 -100 M⍀ micropipette filled with 3 M KCl. EYFP-expressing cells were impaled with the microelectrode and electrode capacitance was nulled. Voltage-activated K ϩ currents were recorded in response to 1.5-s voltage steps to potentials between Ϫ140 and ϩ 50 mV in 10 mV increments, from a holding potential of Ϫ70 mV. Recording pipettes contained (mmol/L): 135 KCl, 1 MgCl 2 , 10 EGTA, 10 HEPES, and 5 glucose; pH 7.2 (300 -310 mosmol/L). The bath solution contained (mmol/L): 117 NaCl, 5.5 KCl, 1.8 CaCl 2 , 2 MgCl 2 , 10 HEPES, and 10 glucose. pH and osmolarity were adjusted to 7.4 and 295-305 mosmol/L, respectively.
Isolation of Embryonic Cardiomyocytes, Cell
Transfection, and Microinjection E9 -9.5 murine embryos were dissected, kept in the yolk sac and put in culture medium (DMEM supplemented with 2% FCS) for 24 h before in situ whole heart experiments. Alternatively, the heart was removed from E14.5 mouse embryos. Atria were separated from ventricles and bathed in ADS buffer. Then cells were isolated with pancreatin and collagenase as previously described (Puceat et al., 1994) . Cells were plated in the same medium as the one used for EBs. Monitoring of Ca 2ϩ spikes in embryonic cardiomyocytes was performed as early as 24 h after their isolation and no longer than 48 h after. No change in cell morphology and Ca 2ϩ homeostasis were observed during the 2-d culture. The day after their isolation, embryonic cardiomyocytes were transfected with Ds Red alone or Ds Red and a plasmid encoding the InsP 3 phosphatase or a pcDNA3.1 plasmid encoding calreticulin, all under control of the CMV promoter. In other experiments, embryonic cardiomyocytes were transfected with the InsP 3 RI antisense construct (see above) together with a plasmid encoding myosin light chain 2v (MLC2v) fused to GFP under the control of the cardiac ␣-actin promoter, in order to track the transfected cells. Transfection was performed with Effectene (Qiagen, Chatsworth, CA) according to the manufacturer's instructions. Cell microinjection was performed as previously described (Bony et al., 2001; Jaconi et al., 2000) . The pipettes contained 2.5 mM fluo-3 (K salt) and 500 g/ml monoclonal 18A10 antiInsP 3 RI antibody or mouse IgGs, or 2.5 mM fluo-3 (K salt) and 3 mg/ml JPW1114.
Imaging of Cytosolic Ca 2؉ Concentration and Membrane Potential
ES cell-derived embryoid bodies, embryonic cardiomyocytes, or whole E9 -9.5 mouse embryos were loaded with 5 M fluo-4/AM (Molecular Probes, Eugene, OR) for 10 -15 min, transferred to the stage of a fast-acquisition epifluorescence confocal microscope and superfused with ADS buffer added with 2 mM Ca 2ϩ . The field was illuminated at 488 nm (Argon laser). Fluo-4 emission fluorescence was recorded through a dichroic mirror (cutoff 510 nm) and a long pass emission filter (cutoff 520 nm) set on a motorized filter wheel. The images were recorded each 30 or 50 ms using a confocal Perkin ElmerCetus Ultraview microscope (Norwalk, CT) coupled to a CCD camera (Coolsnap, Princeton Scientific Instruments, Monmouth Junction, NJ) and digitized on line by a computer (Metamorph software, Universal Imaging, West Chester, PA). To calculate the frequency and synchronization of Ca 2ϩ spikes in embryoid bodies, regions of interest were selected in cells within a beating area and the average pixel intensity was plotted as a function of time. All experiments were performed at 35 Ϯ 2°C and were repeated at least three times. To simultaneously record fluo-3 and JPW1114 fluorescence, cells were bathed in a culture dish set on the stage of a Meta LSM 510 Zeiss microscope (Thornwood, NY) warmed at 37°C. Cells were illuminated at 488 or 514 nm using the Argon laser, and fluorescence was recorded by the photomultipliers after crossing a HFT 488 and NFT 545 dichroic mirrors and two bandpass filters at 505-530 nm (fluo-3) or 620 -670 nm (JPW114). Images were acquired each 50 -70 ms by scanning a small region of interest within the cell.
To estimate the release of Ca 2ϩ from the ER, 1 M thapsigargin was superfused in the absence of Ca 2ϩ to fluo-4 -loaded spontaneously Ca 2ϩ spiking E14 embryonic myocytes overexpressing calreticulin or to mock cells. The amplitude of the Ca 2ϩ release was estimated when a plateau was reached. The maximal rate of increase in cytosolic Ca 2ϩ concentration ([Ca 2ϩ ] c ) was fitted using a sigmoidal equation after normalization of values to the maximal value of fluorescence and was expressed as the t 1/2 required to reach the plateau.
Immunocytochemistry
For immunostaining, embryoid bodies or cells were fixed with 3% paraformaldehyde, permeabilized with 0.1% Triton X-100, and labeled with a mouse antisarcomeric ␣-actinin antibody (Sigma, St. Louis, MO) or with an anti-␤MHC antibody and Alexa350 -or Alexa546 -conjugated anti-mouse IgG (Molecular Probes) or with an anticalreticulin or anti-InsP3RI antibody and a secondary Alexa488 -or Alexa546 -conjugated anti-rabbit IgG (Molecular Probes). In situ immunostained sarcomeres were visualized in 0.3-m optically z-sectioned embryoid bodies. To improve resolution and signal-to-noise ratio, images were restored using the Huygens software (Huygens 2.2.1, Scientific Volume Imaging, Hilversrum, The Netherlands) and visualized using Imaris (Bitplane, Zurich, Switzerland). Calculations were performed on Dell Precision 450 workstations (Round Rock, TX).
RNA Extraction, Reverse Transcription Reaction, and Real-time Quantitative PCR by SYBR Green Detection
Total RNA was isolated from embryoid bodies using an RNA extraction kit (RNeasy, Qiagen, France). One microgram of RNA was reverse-transcribed using the M-MLV reverse transcriptase (Invitrogen, Cergy, France) and used in real-time PCR.
The nucleotide sequences of the PCR primers used were as follows: MEF2C forward: 5Ј-AGATACCCACAACACACCACGCGCC-3Ј and reverse: 5Ј-ATC-CTTCAGAGAGTCGCATGCGCTT-3Ј; Nkx2.5 forward: 5Ј-TGCAGAAG-GCAGTGGAGCTGGACAAGCC-3Ј and reverse: 5Ј-TGCACTTGTAG-CGACGGTTCTGGAACCAG-3Ј; ␤-tubulin forward: 5Ј-CCGGACAGTGTGG-CAACCAGATCGG-3Ј and reverse: 5Ј-TGGCCAAAAGGACCTGAGCG-AACGG-3Ј; HCN1 forward: 5Ј-CAAGACAGCCAGAGCACTTCGT-3Ј and reverse: 5Ј-AGATACATACACCAGTGGGAAGAG-3Ј; HCN2 forward: 5Ј-TCGTCTTCAACGTGGTCTCG-3Ј and reverse: 5Ј-ACAACACGGAGAT-CATCCTGGAC-3Ј (Yasui et al., 2001 ); HCN4 forward: 5Ј-GGATTATCCAC-CCCTACAG-3Ј and reverse: 5Ј-GTCTCGCCAAGTCAATGAGGAAGAAT-3Ј; EYFP forward: 5-ACGTAAACGGCCACAAGTTC-3Ј and reverse: 5Ј-AAGTCGTGCTGCTTCATGTG-3Ј; MLC2a forward: 5Ј-TCTTCTAATGTCT-TCTCAATGTTCG-3Ј and reverse: 5Ј-TCTACTCCTCTTTCTCATCC; CCGTG-3Ј; MLC2v forward: 5Ј-GCCAAGAAGCGGATAGAAGG-3Ј and reverse: 5Ј-CTGTGGTTCAGGGCTCAGTC-3Ј; ␣-MHC forward: 5Ј-CCAAT-GAGTACCGCGGTGAA-3Ј and reverse: 5Ј-ACAGTCATGCCGGGATGAT-3Ј; Cx45 forward: 5Ј-TGTGTGCAACACAGAGCAGC-3Ј and reverse: 5Ј-CC-ATCCTCTCGAATTCGTCG-3Ј. Real-time quantitative PCR was performed using a LightCycler rapid thermal cycler (Roche, Meylan, France). Amplification was carried out as recommended by the manufacturer. Twelve-microliter reaction mixture contained 10 l of Light Cycler-DNA Master SYBR Green I mix (FAST Start KIT, containing TaqDNA polymerase, reaction buffer, deoxynucleoside trisphosphate mix, and SYBR Green I dye), added with 3 mM MgCl 2, 0.5 M of appropriate primer mix, and 2 l of cDNA. Results were expressed as a function of the level of expression of the gene of interest in first stage of differentiating EBs using a previously described mathematical model (Pfaffl et al., 2002) . The data were normalized by PCR analysis of ␤-tubulin. The amplification program included the initial denaturation step at 95°C for 8 min, and 40 cycles of denaturation at 95°C for 3 s, annealing at 65°C for 10 s, and extension at 72°C for 10 s. The temperature transition rate was 20°C/s. Fluorescence was measured at the end of each extension step. After amplification, a melting curve was acquired by heating the product at 20°C/s to 95°C, cooling it at 20°C/s to 70°C, keeping it at 70°C for 20 s, and then slowly heating it at 0.1°C/s to 95°C. Fluorescence was measured through the slow heating phase. Melting curves were used to determine the specificity of PCR products, which was confirmed using conventional gel electrophoresis.
The Student's t test was used to analyze statistical significance. All p values corresponded to two-tailed test, and p Ͻ 0.05 was considered statistically significant.
Western Blotting
For Western blotting, embryoid bodies were lysed using RIPA buffer (20 mM Tris-HCl, pH 7.8, 150 mM NaCl, 1% Triton X-100, 1% deoxycholic acid, 1 mM EDTA, 0.05% SDS) supplemented with phenylmethylsulfonyl fluoride. Protein concentrations were determined by Bio-Rad protein assay (Bio-Rad, Richmond, CA). Proteins (50 g) were fractionated by SDS-PAGE, electroblotted onto a nitrocellulose transfer membrane, and probed with an anti-calreticulin antibody. Antibodies were visualized by addition of goat HRP-conjugated anti-rabbit IgGs and enhanced chemiluminescence reagents (ECL reagent, Amersham Pharmacia Biotech Europe, Freiburg, Germany).
RESULTS
Engineering of Pacemaker Cells from ES Cells
When cultured in high serum medium, ES cells aggregate within an EB, a three-dimensional cell formation that includes the three embryonic layers, and then spontaneously differentiate into myocytes featuring all cardiac phenotypes (i.e., ventricular and atrial cells including sino-atrial cells; Maltsev et al., 1994) . To locate pacemaker cells among myocytes differentiating within embryoid bodies (Meyer et al., 2000) , we engineered an ES cell clone expressing the EYFP. Expression of EYFP was driven by the cardiac-specific ␣ isoform of myosin heavy-chain (␣-MHC) promoter, functional in E7 embryos, and early developing embryonic atria, where differentiation of pacemaker cells originates (Lyons et al., 1990; Moorman and Lamers, 1999; Morkin, 2000;  Figure 1A ). EYFP-expressing cells were small and displayed mostly a round or elongated shape ( Figure 1B , inset). They were dispersed in the embryoid bodies within large fields of cardiomyocytes ( Figure 1B ). In comparison, ES cells in which the expression of EYFP was driven by the broadly functional cardiac ␣-actin promoter (Behfar et al., 2002) produced clusters of large myocytes ( Figure 1C ). This suggests that the activity of the ␣-MHC promoter is significantly restricted among differentiating cardiac cells at early stages of development of embryoid bodies. Cardiac sarcomeres in the EBs were visualized at high magnification by immunofluorescence, using an antibody against sarcomeric actinin. Figure 1D shows that cells expressing EYFP under the transcriptional control of the ␣-MHC promoter featured a poor myofibril network. Furthermore, cells expressing EYFP under the transcriptional control of ␣-MHC did not express the ␤ isoform of myosin heavy chain (␤-MHC) while surrounded by contractile ␤-MHC-positive cells ( Figure 1E ). Videomicroscopy showed that they were not beating (Supplementary Video) while driving contractions of the neighbor myocytes, suggesting that they might be pacemaker cells. To obtain further insight into the phenotype of EYFP-expressing cells, they were microdissected out of the EBs using a laser-assisted device or a microscalpel followed by real-time RT-PCR analysis as well as electrophysiological recordings. Figure 1F shows that these cells contained a high level of mRNAs encoding connexin 45, as well as HCN4, two well-known markers of mouse sinoatrial cells (Moosmang et al., 2001; Verheijck et al., 2001) . No expression of mRNA encoding HCN1 or HCN2 was found in these cells (unpublished data). ES cell-derived EYFP-expressing cells displayed spontaneous action potentials (APD90 ϭ 176 Ϯ 4 ms at 25°C, n ϭ 6) starting with a slow diastolic depolarization, typical of sino-atrial cells ( Figure 1G ). Patchclamp technique was used to test the presence or absence of functional I f channels in ES cell-derived EYFP-expressing cardiomyocytes dissected out of EBs at days 9 and 11 of differentiation. Hyperpolarizing pulses from Ϫ30 to Ϫ140 mV were applied to EYFP-expressing cells, from a holding potential of Ϫ70 mV (see inset Figure 1H ). At day 9 of differentiation, the presence of a small inward depolarizing K ϩ current with electrophysiological properties similar to native I f current recorded in sino-atrial node cells of adult mouse hearts (Mangoni and Nargeot, 2001 ) was observed in only two of the eight cells analyzed, albeit of small amplitude. The other six cells only expressed an inward background K ϩ conductance with small density ( Figure 1H ). On the contrary, in cells isolated from day 11 EBs, I f current was recorded in all EYFP-positive cells. Density and activation time constants of I f current were 24.9 Ϯ 7.5 pA/pF and 503 Ϯ 63 ms at Ϫ140 mV (n ϭ 6), respectively. Interestingly, the current/voltage relationships of total inward and outward voltage-gated K ϩ currents, obtained at days 9 and 11 of differentiation (Figure 1H ), demonstrated no difference in the current density of outward voltage-gated K ϩ currents.
Combined, our findings demonstrate that cells expressing EYFP under the transcriptional control of the ␣-MHC promoter display all essential hallmarks of pacemaker cells. We have thus established a cell model which recapitulates in vitro the formation of pacemaker cells.
Voltage-sensitive Ionic Conductances Do Not Underlie Automaticity of ES Cell-derived Pacemaker Cells
In excitable muscle cells, spontaneous electrical activity is translated into spontaneous Ca 2ϩ spiking. Thus, the latter phenomenon can be used as a read-out of pacemaker activity. To further test the involvement of a voltage-sensitive ionic current in pacemaker activity of day 9 whole embryoid bodies, 140 mM KCl was applied to spontaneously Ca 2ϩ -spiking cells, within fluo-4 -loaded embryoid bodies to abolish membrane potential. A sudden and sustained increase in basal Ca 2ϩ was observed upon depolarization of cells. More interestingly, despite the annihilation of the membrane potential, rhythmic Ca 2ϩ oscillations were still observed when basal Ca 2ϩ reached a plateau (Figure 2A ). To more specifically establish a participation, if any, of the I f current in spontaneously Ca 2ϩ -spiking cells, ivabradine or zeneca (ZD7288), two inhibitors of I f conductance (BoSmith et al., 1993; Bucchi et al., 2002) , were applied to day 9 fluo-4 -loaded embryoid bodies. Both drugs had no effect on spontaneous Ca 2ϩ spiking activity of ES cell-derived cardiomyocytes ( Figure 2B ) as expected from the lack of functional I f current in ES cell-derived pacemaker cells in day 9 embryoid bodies ( Figure 1H ). Similarly, when tested on E9.5 embryonic hearts in situ, both ivabradine and zeneca (ZD7288) had no effect on their spontaneous Ca 2ϩ -spiking activity (Supplementary Figure S1 ). This indicates that at early stages of cardiogenesis, the I f current does not play any role in pacemaker activity. In contrast, 2 d later, in day 11 embryoid bodies, a stage at which a functional I f current was recorded in ES cell-derived pacemaker cells ( Figure 1H ), both I f current inhibitors slowed down the rate of spontaneously spiking ES cell-derived cardiac cells and changed the decay of the Ca 2ϩ transient ( Figure 2C ). In line with this result, depolarization of the cells with 140 mM KCl increased basal Ca 2ϩ and stopped Ca 2ϩ oscillations recorded within embryoid bodies ( Figure 2D ). We conclude that the I f current is functional only at day 11 of differentiation of ES cells. Thus, another voltage-insensitive pacemaking mechanism must account for cardiac automaticity during heart formation at early embryonic stages.
Overexpression of Calreticulin in Pacemaker Cells Impairs Their Spontaneous Activity
Intracellular Ca 2ϩ signaling is disrupted by increased levels of calreticulin in the ER (Krause and Michalak, 1997) . Elevated expression of calreticulin leads to increased concentrations of Ca 2ϩ in the lumen of the ER in nonexcitable cells (Mery et al., 1996) and to a concomitant inhibition of capacitative Ca 2ϩ influx (Mery et al., 1996; Fasolato et al., 1998) as well as inhibition of SERCA (John et al., 1998) . This limits Ca 2ϩ entry into the ER, and in turn impairs Ca 2ϩ efflux from the ER (Xu et al., 2000) . Besides, buffering ER luminal Ca 2ϩ revealed that the filling state of the ER regulates the extent of InsP 3 -triggered Ca 2ϩ release through a mechanism independent from cytosolic Ca 2ϩ or refilling by the sarco-ER Ca signaling prompted us to manipulate its intracellular expression in ES cell-derived pacemaker cells to investigate the role of InsP 3 -sensitive Ca 2ϩ stores in triggering embryonic cardiac excitability. We generated an ES cell line in which calreticulin is expressed under the transcriptional control of the ␣-MHC promoter (designed as ␣-MHC-CRT). As described above, this effectively targets overexpression of calreticulin to pacemaker cells. ␣-MHC-CRT ES cells were allowed to differentiate within EBs into cardiomyocytes including pacemaker cells (inset in Figure 3 ). Figure 3 shows that the embryoid bodies derived from ␣-MHC-CRT ES cells exhibited a dramatic reduction in the beating activity of cardiomyocytes differentiating within the mesoderm. Wild-type CGR8 ES cells differentiated into cardiomyocytes within 9 -12 d, as shown by a high percentage (67 Ϯ 16%) of spontaneously contracting EBs. In contrast, in a population of EBs containing pacemaker cells that overexpressed calreticulin, only 23 Ϯ 4% were beating at day 12 ( Figure 3A) . However, buffering Ca 2ϩ by calreticulin in the ER of pacemaker cells did not affect expression of mRNAs encoding cardiac-specific transcription factors (i.e., Nkx2.5 and Mef2C; Supplementary Figure S2) . Similarly, myofibrillogenesis as assessed by anti-␣-actinin immunostaining was normal in EBs containing pacemaker cells that overexpressed calreticulin. Furthermore, both atrial and ventricular myosin light chains were expressed normally in EBs that overexpressed calreticulin (Supplementary Figure S3) .
To further delineate the phenotype of pacemaker cells overexpressing calreticulin, Ca 2ϩ -spiking activity was imaged in day 8 -10 fluo-4 -loaded EBs, before appearance of a functional I f current (Figure 2) . Cardiomyocytes in the wildtype EBs showed synchronous and vigorous Ca 2ϩ spikes, with a rate (1 Hz at 35°C) similar to the one of the action potentials of ES cell-derived pacemaker cells (0.8 Hz at 25°C, Figure 1 ), whereas those in the EBs with pacemaker cells that overexpressed calreticulin displayed weak and asynchronous Ca 2ϩ transients ( Figure 3B ). Thus, buffering intraluminal ER Ca 2ϩ and limiting capacitative Ca 2ϩ influx by high expression of calreticulin in pacemaker cells have an inhibitory effect indicating that homeostasis of ER Ca 2ϩ stores plays a crucial role in generation of early pacemaker activity in developing embryoid bodies.
InsP 3 -induced Ca
2؉ Release Is Required for Pacemaker Activity Because the excitability of cardiomyocytes in EBs was severely compromised when the pacemaker cells overexpressed calreticulin, we hypothesized that repetitive InsP 3 -induced Ca 2ϩ release from the ER plays an essential role in early cardiac automaticity. To get more insight into the role of the InsP 3 -dependent pathway in mediating pacemaker activity, we tested an alternative genetic approach to disrupt Ca 2ϩ cycling within the pacemaker cell. An ES cell line was generated to express specifically in the pacemaker cells an InsP 3 receptor antisense cDNA under the transcriptional control of the ␣-MHC promoter (Figure 4) , an approach previously reported as successful to disrupt InsP 3 signaling in T-cells (Jayaraman et al., 1995) . The antisense dramatically decreased the number of type I InsP 3 receptors, the major InsP 3 receptor isoform expressed in these cells (unpublished data) as shown by immunostaining embryonic cardiac cells expressing the antisense with a specific anti-type I InsP 3 receptors antibody ( Figure 4A) . Differentiation of the genetically modified ES cells (InsP 3 R antisense) within embryoid bodies recapitulated the phenotype of the embryoid bodies with pacemaker cells overexpressing calreticulin. Beating activity was severely impaired ( Figure 4B ). In line with the weak contractility, spontaneous Ca 2ϩ spiking within embryoid bodies in which pacemaker cells expressed the InsP 3 RI antisense was weak and an infrequent event ( Figure 4C ). Differentiation per se of ES cells into cardiomyocytes was not affected as revealed by the presence of abundant actininpositive cardiac cells within the embryoid bodies (Supplementary Figure S4 ).
To further address the role of InsP 3 receptors, we used xestospongin C, the most specific InsP 3 receptor antagonist (Gafni et al., 1997) . In the presence of xestospongin C at a low concentration (5 M), which does not affect Ca 2ϩ reuptake by the ER (De Smet et al., 1999) , spontaneous Ca 2ϩ transients recorded within day 8 -10 EBs were stopped within 5 min ( Figure 4D) . Similarly, applied to whole E9.5 mouse embryos, the InsP 3 RI antagonist desynchronized and abolished Ca 2ϩ spiking in both the atrial and ventricular primordia of embryonic heart. Washing the drug out allowed a slow recovery of fast Ca 2ϩ transients ( Figure 4E ).
InsP 3 Regulates Pacemaker Activity of E14.5 Embryonic Pacemaker Cells ⌭mbryonic (E14.5) atrial cells in which ␣-MHC is transiently expressed ( Figure 1A ) include a population of pacemaker cells. We wanted to address whether InsP 3 -induced Ca 2ϩ cycling also underlies pacemaker activity of these cells at a stage of differentiation far more advanced than ES cellderived pacemaker cells in D8 -10 EBs. To induce a fast hydrolysis of InsP 3, we used InsP 3 phosphatase expressed in atrial cells isolated from E14.5 embryonic hearts and plated at low density. Spontaneous Ca 2ϩ spiking in isolated cells was used as a criterion to track pacemaker cells among the atrial cells. Such pacemaker cells represented a population of 6% of E14.5 atrial cells and featured a developed ER as shown by the presence of high levels of calreticulin and InsP 3 RIs ( Figure 5A ). Automatic activity (i.e., Ca 2ϩ spiking) was scored in InsP 3 phosphatase-and Ds Red-coexpressing cells versus cells expressing only Ds Red. Figure 5B shows that hydrolysis of InsP 3 by the phosphatase prevented automaticity in 77% of pacemaker atrial cells.
Next, we used a specific anti-InsP 3 RI antibody (clone 18A10) to block receptor function (Nakade et al., 1991) . The antibody or mouse IgGs as a control were microinjected into atrial embryonic pacemaker cells together with fluo-3. The antibody prevented Ca 2ϩ spiking in 65% of atrial pacemaker cells ( Figure  5C ). In line with the previous findings, xestospongin C blunted both spontaneous Ca 2ϩ -spiking and firing of action potential simultaneously monitored in fluo-3 and JPW1114 injected atrial pacemaker cells ( Figure 5D ). Altogether, these findings demonstrate that InsP 3 must be a key messenger to mediate pacemaker activity in embryonic hearts.
DISCUSSION
The molecular and subcellular keystones of pacemaker activity in early stages of cardiogenesis, before appearance of the I f pacemaker current, have not been understood at the subcellular level. Here, we uncovered that intracellular Ca 2ϩ signaling emanating from the ER in embryonic pacemaker cells is essential for cardiac cell automaticity. We demonstrate that depolarization of pacemaker cells in early embryonic pacemaker cells is triggered by InsP 3 -sensitive intracellular Ca 2ϩ stores. Furthermore, this early pacemaker mechanism is preserved throughout murine development and works together with the I f current-based mechanism in fetal pacemaker cells.
Engineering of ES Cell-derived Pacemaker Cells
Using the ␣-MHC promoter to drive expression of EYFP in CGR8 ES cells, we established a model of early cardiac pacemaker cells. The ES cell-derived pacemaker cells featured a poor myofibrillar network and did not beat while driving contraction of surrounding cells. This suggests that the cells generated and propagated an electrical signal. Indeed, the membrane potential of the pacemaker cells was unstable, triggering spontaneous and rhythmic firing of action potentials. The depolarizing phase of the action potential was composed of a slow and then a very fast upstroke, a time course typical of pacemaker cells of the sino-atrial node (Mangoni and Nargeot, 2001 ). These cells also expressed connexin 45, a specific isoform of connexin whose expression is restricted to nodal cells (Verheijck et al., 2001) and HCN4, although not yet functional at early stages of cell differentiation but becoming operative in later stages. 
Impaired InsP 3 -dependent Ca 2؉ Signaling Prevents Pacemaker Activity But Not Cardiac Cell Differentiation in Early Cardiogenesis
We disrupted the intracellular Ca 2ϩ signaling network by buffering ER Ca 2ϩ and preventing ER refilling by calreticulin or altered expression of InsP 3 RIs by using an antisense cDNA. In both cases, the expression of the transgene was driven by the ␣-MHC promoter to target the Ca 2ϩ binding protein or the InsP 3 RI antisense cDNA to CGR8 ES cellderived pacemaker cells. Ca 2ϩ spiking activity and in turn contractility of cardiomyocytes within EBs were severely impaired. Buffering ER Ca 2ϩ and limiting ER refilling by calreticulin or inhibiting Ca 2ϩ release by an InsP 3 RI antisense in pacemaker cells did not, however, prevent differentiation per se, because the cardiomyocytes showed normal expression of cardiac-specific transcription factors (i.e., Nkx2.5 and Mef2C) and normal myofibrillogenesis. Although a role of calreticulin has been suggested in the retinoic acid receptor signaling pathway (Shago et al., 1997) , a key pathway in cardiac cell specification (Xavier-Neto et al., 1999; Harvey, 2002) , both atrial and ventricular myosin light chains were expressed normally in EBs that overexpressed calreticulin. This demonstrates that atrio-ventricular specification did occur. This was expected from the fact that calreticulin overexpression was restricted to noncontractile pacemaker cells. We conclude that pacing is not required for cardiogenesis from ES cells as previously observed (Yang et al., 2002) . However, the excitability of cardiomyocytes was severely compromised in EBs that contained pacemaker cells overexpressing calreticulin or featuring an altered InsP 3 RI expression.
The phenotype of pacemaker cells with disrupted InsP 3 -dependent Ca 2ϩ signaling contrasts with the one of ryanodine-deficient ES cell-derived cardiomyocytes that show no inhibition of beating activity or amplitude of the Ca 2ϩ transients, but only modifications in their beating frequency (Yang et al., 2002) . This demonstrates that Ca 2ϩ release via InsP 3 receptors, and not via ryanodine receptors, plays a key role in the excitability of early pacemaker cells. This might have been expected from a negligible expression of calsequestrin and a not yet developed T-tubule system in ES cell-derived cardiomyocytes within day 9 -12 EBs, as assessed by PCR and immunofluorescence (unpublished data).
Early Pacemaker Activity Is Triggered by Ca
2؉ Cycling In and Out of the ER through InsP 3 Rs During early cardiac cell differentiation of ES cells, spontaneous action potentials do not depend on membrane potential but rather on intracellular Ca 2ϩ stores. It has been suggested that intracellular Ca 2ϩ oscillations activate a Ca 2ϩ -dependent voltage-insensitive nonspecific cationic conductance and/or of Na ϩ /Ca 2ϩ exchange, generating depolarizing currents and in turn action potentials (Viatchenko-Karpinski et al., 1999) . Although the molecular and subcellular components of this mechanism remain unclear, it applies to pacemaker cells of the gastrointestinal tract (Ward et al., 2000) and is functional in the E9 mouse embryonic heart (Koushik et al., 2001 ) before the pacemaker I f current becomes predominant (Yasui et al., 2001; Stieber et al., 2003) .
We focused our investigation on the intracellular signaling components that could periodically generate cytosolic Ca 2ϩ increase to activate the depolarizing voltage-independent conductances. We now report that shuttle of Ca 2ϩ in and out of the ER provides an oscillatory membrane-depolarizing mechanism, which triggers the pacemaker activity. Indeed, overexpression of calreticulin in nonexcitable cells has been shown to limit Ca 2ϩ entry into the cell (Mery et al., 1996; Fasolato et al., 1998) and in turn to impair Ca 2ϩ mobilization from the ER (Xu et al., 2000) . Calreticulin also features a chaperoning function (Michalak et al., 1999) and its overexpression may affect the processing and/or folding of other membrane-associated proteins involved in excitation of a cardiomyocyte. Although such an effect cannot be excluded, we found that calreticulin overexpression in excitable spontaneously spiking embryonic cardiomyocytes slows down thapsigargin-induced Ca 2ϩ -release. It further dampens down the total amount of free Ca 2ϩ released by the SERCA inhibitor, possibly after inhibition of the capacitative Ca 2ϩ influx on a spike to spike basis and/or inhibition of SERCA (John et al., 1998) . Therefore, both a Ca 2ϩ buffering effect in the ER and a limited pool of releasable Ca 2ϩ might contribute to decrease the rate of Ca 2ϩ oscillations. Although the exact mechanism by which calreticulin inhibits Ca 2ϩ efflux from the ER requires further investigation in excitable cells, overexpression of the protein prevents Ca 2ϩ -dependent generation of depolarizing currents in ES cell-derived cardiac pacemaker cells. Similarly, disturbed expression of InsP 3 RIs in ES cell-derived pacemaker cells by the antisense cDNA limits Ca 2ϩ release from the stores and thus activation of the Ca 2ϩ -sensitive depolarizing membrane conductance. Altogether, the results obtained using the genetically modified ES cells (calreticulin overexpressing-and InsP 3 RI antisense-expressing pacemaker cells) point to a key role of Ca 2ϩ cycling in and out of the ER for the initiation of pacemaker activity in early cardiogenesis (Figure 6 ). Indeed, a Ca 2ϩ spike and in turn rhythmic oscillations of Ca 2ϩ and membrane potential can be initiated only if the cell Ca 2ϩ load including free ER Ca 2ϩ , buffered Ca 2ϩ and cytosolic Ca 2ϩ is above a threshold. If the Ca 2ϩ load drops below threshold because of disrupted InsP 3 signaling (inhibition by xestospongin C, InsP 3 RI antisense) or impaired CCI or SERCA activity (calreticulin overexpression), leading to a limitation of free ER Ca 2ϩ to provide sufficient driving force for efflux from the ER, the cell is unable to trigger a Ca 2ϩ spike (Sneyd et al., 2004) . As a result, there can be no activation of the Ca 2ϩ -sensitive depolarizing conductance responsible for spontaneous action potentials firing, as further shown by inhibition of the later phenomenon by xestospongin C ( Figure 5D ).
The InsP 3 -based pacemaking mechanism is conserved throughout murine development. In E14.5 embryonic atrial cells, accelerating the hydrolysis of InsP 3 by overexpressing InsP 3 phosphatase or directly blocking the InsP 3 receptor by microinjection of a specific antibody (Nakade et al., 1991; Miyazaki et al., 1992) dramatically impaired spontaneous Ca 2ϩ -spiking activity of isolated pacemaker cells. Xestospongin C also blunted spontaneous Ca 2ϩ -spiking activity in E9.5 embryonic heart. Thus, the intracellular Ca 2ϩ signaling network conserved the ability to regulate the cardiac pacemaker throughout development. Besides ionic conductance (i.e., I f , Ca 2ϩ currents), our findings reveal in the fetal life a second cardiac pacemaking mechanism mediated by intracellular Ca 2ϩ cycling. Whether this Ca 2ϩ -dependent mechanism is a regulator or is required together with the I f current-dependent pacemaking activity and maintained in the adulthood, a stage at which InsP 3 RIs are confined to the conduction system (Gorza et al., 1993) , remains to be elucidated.
In this study, we provide direct evidence that ER-mediated Ca 2ϩ dynamics are important in excitable cells at both embryonic and fetal stages. Movement of Ca 2ϩ in and out of the ER plays a crucial role in the excitability of embryonic cardiomyocytes. Overstimulation of the InsP 3 -dependent pathway or perturbation of Ca 2ϩ homeostasis in pacemaker cells during cardiac development may then be at the origin of rhythm-related cardiac diseases at the adult stage. Indeed, taking into account the refractory period of the conductive cells, a change in pulse frequency and/or rhythm after alteration of ER Ca 2ϩ cycling in pacemaker cells is likely to lead to a conduction block, as observed in mice overexpressing calreticulin in the heart (Nakamura et al., 2001) . Figure 6 . Model of InsP 3 -induced spontaneous activity in embryonic pacemaker cells. Ca 2ϩ released upon InsP 3 binding to its receptor activates a depolarizing conductance (Na ϩ /Ca 2ϩ exchanger and/or a nonspecific cationic and depolarizing conductance) and thus triggers action potential firing. CCI allows for refilling the ER. This Ca 2ϩ cycling acting in a rhythmic and perpetual manner is a predominant pacemaking mechanism in early cardiogenesis and regulates or is required together with the I f current as a basis of fetal pacemaking mechanism.
